Tag: Abbott
Abbott Receives FDA Approval for Gallant Heart Rhythm Implants Featuring Continuous Remote Monitoring
Abbott won FDA approval for its next-generation Gallant implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices. Cleared in Europe earlier this...
Abbott’s Freestyle Libre 2 iCGM Receives FDA Clearance For Adults And Children With Diabetes...
Abbott, the worldwide leader in continuous glucose monitoring (CGM), received FDA clearance for its FreeStyle Libre 2 integrated continuous glucose monitoring (iCGM) system for...
COVID-19 Pandemic Will Propel US Telehealth Market To Grow At A CAGR of Over...
The US telehealth market is expected to grow at a CAGR of over 29% during the period 2019–2025, according to a study published in...
Abbott-Insulet Collaboration to Combine Abbott’s CGM with Insulet’s Omnipod Horizon Automated Insulin Delivery System
Abbott and Insulet are partnering to integrate Abbott's world-leading continuous glucose monitoring (CGM) technology with Insulet's next-generation tubeless system, the Omnipod Horizon Automated Insulin...
Abbott Secures FDA’s Expanded Indication for its Deep Brain Stimulation System for Parkinson’s Treatment
Abbott’s Infinity Deep Brain Stimulation (DBS) system has received an expanded clearance from the U.S. Food and Drug Administration (FDA) to include targeting of...
Bigfoot Biomedical Announces $45 Million Series C Financing Led by Abbott
Bigfoot Biomedical, a diabetes startup creating insulin delivery through the use of AI and automation has raised $45 million in the initial tranche of...